Skip to main content

Novel Rx

      Rheumatology Round-Up with Drs. Kavanaugh & Cush

      The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.

      The axSpa diagnosis, imaging and treatments: Dr. Lianne Gensler

      Dr. Lianne Gensler reviews several SpA abstracts and a session on MRI presented at the 2020 ACR annual meeting. Abstracts reviews: abstract #1883, #2014, #L11 and #2022

       

      Dr. Ken Saag - RECIPE Study: MMF with Pegloticase

      Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.

      Flu and Tofacitinib: Dr. Kathryn Dao

      Dr. Kathryn Dao reviews abstract L04 at the 2020 ACR annual meeting.

      GCA Treatment Data: Dr. David Liew Abstract

       

      Dr. David Liew reviews abstracts #0516 and #0513 presented at the 2020 ACR annual meeting.

      ABCs of RA: Panel Discussion with Dr. Jonathan Kay

      They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.

      Roundtable on Gout: What's Hot at ACR 2020 with Gout Faculty

      Drs. Michael Pillinger, Naomi Schlesinger and Robert Keenan discuss the hot topics in Gout in a panel discussion at ACR 2020.

      Anakinra in Pediatric, Adult Still's Disease: Dr. Bella Mehta

      Dr. Bella Mehta reviews abstract #1633 at the 2020 ACR annual meeting. 

       

      Potpourri of Pathotypes of Predictors with RA Faculty

      Dr. Jonathan Kay again leads an international panel of rheumatologists to elicit their opinions on key abstracts at ACR 2020. Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks.

      Pegloticase in Severe Refractory Gout: Dr. Olga Petryna

      Dr. Petryna reviews several pegloticase-related abstracts presented at the ACR 2020 annual meeting, including abstracts #0683 and #0677

      SKIPPAIN Trial: Dr. Sheila Reyes

      Dr. Sheila Reyes reviews abstract #0899 presented at the 2020 ACR annual meeting.

      Improving Response to Pegloticase: Dr. Nicola Dalbeth

      Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.

      Nomenclature, Uveitis and Other Spondyloarthritis Features: Dr. Lianne Gensler

      Dr. Gensler reviews her top selections for ACR 2020 today, including abstract #0881 and #0876. She also highlighted the study group on spondyloarthritis, which focused on nomenclature.  

      Combo Therapy v Monotherapy (SEAM-RA Trial): Dr. Richard Conway

      Dr. Conway discusses ACR abstract #0939 presented Saturday at the 2020 ACR annual meeting.

      Treatment of Dermatomyositis Studies: Dr Robert Chao

      Dr. Robert Chao reviews two important abstracts - #0955 (IVIg) and #0958 (tocilizumab) - on the treatment of dermatomyositis as presented at the 2020 ACR annual meeting. 

      ×